Shanghai Healthcare Capital

Shanghai Healthcare Capital operates as a specialized life sciences investment fund, strategically backing innovative companies across biotechnology, medical devices, and the broader healthcare spectrum. Approved by the Shanghai Municipal People's Government and initiated by the SIIC Group, this municipal-level fund targets growth opportunities, deploying capital to advance industry innovation.

Established in 2020, Shanghai Healthcare Capital stemmed from a strategic initiative by the Shanghai Municipal People's Government, with the SIIC Group as its primary initiator. The core insight was to cultivate and bolster Shanghai's biomedical industry, enhancing its stature as a global hub for life sciences innovation.

The fund primarily serves innovative companies in drug discovery and medical technologies, providing investment and strategic guidance. Shanghai Healthcare Capital’s mission is to fuel these pioneering companies, fostering a vibrant ecosystem. The firm envisions solidifying Shanghai's position as a preeminent global center for biomedical research and application.